We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$5.2B
AUM Growth
-$91.8M
Cap. Flow
-$238M
Cap. Flow %
-4.58%
Top 10 Hldgs %
22.29%
Holding
328
New
43
Increased
93
Reduced
100
Closed
61

Top Buys

Rank Stock Value
1
SYK icon
Stryker
SYK
+$38.2M
2
CCL icon
Carnival Corporation Ltd
CCL
+$37.7M
3
WBA
Walgreens Boots Alliance
WBA
+$35.3M
4
ICLR icon
Icon
ICLR
+$30.9M
5
CELG
Celgene Corp
CELG
+$29.8M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$63.8M
2
DHR icon
Danaher
DHR
+$50.4M
3
AZO icon
AutoZone
AZO
+$36.8M
4
AGN
Allergan plc
AGN
+$33.9M
5
BIIB icon
Biogen
BIIB
+$33.5M

Sector Composition

Rank Sector Weight
1 Technology 25.03%
2 Healthcare 24.38%
3 Financials 20.66%
4 Communication Services 10.61%
5 Consumer Discretionary 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBRA icon
226
Sabra Healthcare REIT
SBRA
$5.64B
$1.29M 0.02%
50,000
– –
ACAD icon
227
Acadia Pharmaceuticals
ACAD
$4.39B
$1.28M 0.02%
30,475
+4,577
+18% +$177K
HCSG icon
228
Healthcare Services Group
HCSG
$1.59B
$1.27M 0.02%
38,372
– –
VRTX icon
229
Vertex Pharmaceuticals
VRTX
$122B
$1.22M 0.02%
9,856
-6,733
-41% -$848K
SHPG
230
DELISTED
Shire pic
SHPG
$1.21M 0.02%
+4,998
New +$1.24M
INCY icon
231
Incyte
INCY
$23.9B
$1.14M 0.02%
+10,977
New +$1.14M
MLNX
232
DELISTED
Mellanox Technologies, Ltd.
MLNX
$1.13M 0.02%
+23,233
New +$1.13M
MCK icon
233
McKesson
MCK
$100B
$1.12M 0.02%
5,000
+2,000
+67% +$462K
HDB icon
234
HDFC Bank
HDB
$119B
$1.08M 0.02%
71,608
-9,912
-12% -$144K
RDUS
235
DELISTED
Radius Health, Inc.
RDUS
$1.05M 0.02%
15,475
-1,867
-11% -$87K
MODN
236
DELISTED
MODEL N, INC.
MODN
$849K 0.02%
71,266
– –
RCPT
237
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$840K 0.02%
+4,421
New +$731K
VIRX
238
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$828K 0.02%
+1,310
New +$696K
HSTO
239
DELISTED
Histogen Inc. Common Stock
HSTO
$803K 0.02%
783
– –
CASH icon
240
Pathward Financial
CASH
$1.82B
$800K 0.02%
55,947
+18,306
+49% +$251K
VIVO
241
DELISTED
Meridian Bioscience Inc
VIVO
$798K 0.02%
42,800
– –
AFMD
242
DELISTED
Affimed
AFMD
$753K 0.01%
+5,588
New +$536K
MO icon
243
Altria Group
MO
$122B
$685K 0.01%
+14,000
New +$710K
AERI
244
DELISTED
Aerie Pharmaceuticals
AERI
$638K 0.01%
36,130
+14,820
+70% +$272K
SAGE
245
DELISTED
Sage Therapeutics
SAGE
$634K 0.01%
+8,685
New +$558K
TSLA icon
246
Tesla
TSLA
$1.21T
$633K 0.01%
+35,415
New +$560K
SPWR
247
DELISTED
SunPower Corporation Common Stock
SPWR
$610K 0.01%
32,768
-82,356
-72% -$1.73M
LAB icon
248
Standard BioTools
LAB
$305M
$604K 0.01%
24,961
+6,280
+34% +$198K
TBRA
249
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$588K 0.01%
34,060
+9,060
+36% +$132K
SUNE
250
DELISTED
SUNEDISON, INC COM
SUNE
$566K 0.01%
19,000
+2,000
+12% +$57K
8 9
10
11 12

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Polar Capital held 328 positions worth $5.2B, down 1.7% from $5.29B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Polar Capital withdrew a net $238M in Q2 2015, closing 61 positions and reducing 100 holdings. Its most notable exit was Danaher, an estimated $50.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Polar Capital opened a new position in Stryker worth $38.5M.

  • Polar Capital's largest Q2 2015 buy was Stryker: 402,973 shares worth $38.5M.
  • Polar Capital added most to Celgene Corp in Q2 2015, an estimated $29.8M increase.
  • Polar Capital's biggest Q2 2015 reduction was Merck, cutting an estimated $63.8M.
  • Polar Capital fully exited Danaher in Q2 2015, selling an estimated $50.4M.
  • Polar Capital's ten largest holdings make up 22% of its $5.2B portfolio in Q2 2015.
  • Polar Capital opened 43 new positions and closed 61 in Q2 2015.
  • Polar Capital's portfolio value fell 1.7% quarter-over-quarter to $5.2B.

Based on Polar Capital's 13F filing for Q2 2015, filed 14 Aug 2015.